Exercise and possible molecular mechanisms of protection from vascular disease and diabetes: the central role of ROS and nitric oxide.
暂无分享,去创建一个
[1] B. Kingwell,et al. The effect of the nitric oxide donor sodium nitroprusside on glucose uptake in human primary skeletal muscle cells. , 2009, Nitric oxide : biology and chemistry.
[2] C. Sobey,et al. Importance of NOX1 for angiotensin II-induced cerebrovascular superoxide production and cortical infarct volume following ischemic stroke , 2009, Brain Research.
[3] R. Blumenthal,et al. Exercise Training for Type 2 Diabetes Mellitus: Impact on Cardiovascular Risk A Scientific Statement From the American Heart Association , 2009, Circulation.
[4] J. Esplugues,et al. Regulation of Oxygen Distribution in Tissues by Endothelial Nitric Oxide , 2009, Circulation research.
[5] R. Curi,et al. Association of NAD(P)H oxidase with glucose-induced insulin secretion by pancreatic beta-cells. , 2009, Endocrinology.
[6] G. McConell,et al. Skeletal muscle glucose uptake during exercise: A focus on reactive oxygen species and nitric oxide signaling , 2009, IUBMB life.
[7] J. Haefliger,et al. Swimming Prevents Vulnerable Atherosclerotic Plaque Development in Hypertensive 2-Kidney, 1-Clip Mice by Modulating Angiotensin II Type 1 Receptor Expression Independently From Hemodynamic Changes , 2009, Hypertension.
[8] M. Turiel,et al. Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of nitric oxide synthase and a novel cardiovascular risk molecule. , 2009, Medical science monitor : international medical journal of experimental and clinical research.
[9] N. Ruderman,et al. AMPK and the biochemistry of exercise: implications for human health and disease. , 2009, The Biochemical journal.
[10] D. Brillante,et al. Arterial stiffness in insulin resistance: The role of nitric oxide and angiotensin II receptors , 2008, Vascular health and risk management.
[11] N. Buus,et al. Novel approaches to improving endothelium-dependent nitric oxide-mediated vasodilatation , 2009, Pharmacological reports : PR.
[12] J. Tanus-Santos,et al. Enhanced concentrations of relevant markers of nitric oxide formation after exercise training in patients with metabolic syndrome. , 2008, Nitric oxide : biology and chemistry.
[13] K. Ramana,et al. l‐Arginine prevents metabolic effects of high glucose in diabetic mice , 2008, FEBS letters.
[14] M. Krause,et al. Type 1 diabetes: can exercise impair the autoimmune event? The L-arginine/glutamine coupling hypothesis. , 2008 .
[15] P. H. D. de Bittencourt,et al. Type 1 diabetes: can exercise impair the autoimmune event? The L‐arginine/glutamine coupling hypothesis , 2008, Cell biochemistry and function.
[16] C. Dejong,et al. Glutamine is an important precursor for de novo synthesis of arginine in humans. , 2008, The American journal of clinical nutrition.
[17] Crystal D. Aultman,et al. Vascular biology of angiotensin and the impact of physical activity. , 2008, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.
[18] C. Baylis. Nitric oxide deficiency in chronic kidney disease. , 2008, American journal of physiology. Renal physiology.
[19] T. Herbert,et al. Distinct glucose-dependent stress r esponses revealed by translational profiling in pancreatic b-cells , 2008 .
[20] Guoyao Wu,et al. Dietary supplementation with watermelon pomace juice enhances arginine availability and ameliorates the metabolic syndrome in Zucker diabetic fatty rats. , 2007, The Journal of nutrition.
[21] Maristela L Onozato,et al. Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems. , 2007, American journal of physiology. Heart and circulatory physiology.
[22] A. Korac,et al. Beneficial effects of L‐arginine–nitric oxide‐producing pathway in rats treated with alloxan , 2007, The Journal of physiology.
[23] M. Brosnan,et al. Homocysteine metabolism in diabetes. , 2007, Biochemical Society transactions.
[24] M. Andersen,et al. Reactive Oxygen Species as a Signal in Glucose-Stimulated Insulin Secretion , 2007, Diabetes.
[25] J. Sowers,et al. Role of phosphatidylinositol 3-kinase/Akt pathway in angiotensin II and insulin-like growth factor-1 modulation of nitric oxide synthase in vascular smooth muscle cells , 2002, Endocrine.
[26] R. Curi,et al. Acute exercise stimulates macrophage function: possible role of NF‐κB pathways , 2007 .
[27] R. Curi,et al. MRP1/GS‐X pump ATPase expression: is this the explanation for the cytoprotection of the heart against oxidative stress‐induced redox imbalance in comparison to skeletal muscle cells? , 2007, Cell biochemistry and function.
[28] D. Leibfritz,et al. Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.
[29] K. Krause,et al. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. , 2007, Physiological reviews.
[30] M. Clark,et al. Acute blockade by endothelin-1 of haemodynamic insulin action in rats , 2007, Diabetologia.
[31] N. V. van Riel,et al. Integration of the metabolic and cardiovascular effects of exercise. , 2006, Essays in biochemistry.
[32] C. Baylis. Arginine, arginine analogs and nitric oxide production in chronic kidney disease , 2006, Nature Clinical Practice Nephrology.
[33] V. Bronte,et al. Regulation of immune responses by L-arginine metabolism , 2005, Nature Reviews Immunology.
[34] A. Othman,et al. l‐Arginine ameliorates oxidative stress in alloxan‐induced experimental diabetes mellitus , 2004, Journal of applied toxicology : JAT.
[35] M. Brand,et al. Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. , 2004, Diabetes.
[36] S. Kahn,et al. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes , 2003, Diabetologia.
[37] A. Steensberg,et al. Exercise and hypoxia: effects on leukocytes and interleukin-6-shared mechanisms? , 2002, Medicine and science in sports and exercise.
[38] M. Wheeler,et al. Exogenous nitric oxide and endogenous glucose-stimulated beta-cell nitric oxide augment insulin release. , 2002, Diabetes.
[39] B. Kingwell,et al. Nitric oxide synthase inhibition reduces glucose uptake during exercise in individuals with type 2 diabetes more than in control subjects. , 2002, Diabetes.
[40] M. Febbraio,et al. Cytokine response to eccentric exercise in young and elderly humans. , 2002, American journal of physiology. Cell physiology.
[41] Guoyao Wu,et al. Regulation of nitric oxide synthesis by dietary factors. , 2002, Annual review of nutrition.
[42] W. Dröge. Free radicals in the physiological control of cell function. , 2002, Physiological reviews.
[43] P. Tsao,et al. Homocysteine Impairs the Nitric Oxide Synthase Pathway: Role of Asymmetric Dimethylarginine , 2001, Circulation.
[44] J. Méndez,et al. Regulation of hyperglycemia and dyslipidemia by exogenous L-arginine in diabetic rats. , 2001, Biochimie.
[45] S. Schoonbroodt,et al. Oxidative stress interference with the nuclear factor- κB activation pathways , 2000 .
[46] D. Harrison. Oxidant Signaling in Vascular Cell Growth , Death , and Survival A Review of the Roles of Reactive Oxygen Species in Smooth Muscle and Endothelial Cell Mitogenic and Apoptotic Signaling , 2000 .
[47] G. Spinas. The Dual Role of Nitric Oxide in Islet β-Cells , 1999 .
[48] P. Newsholme,et al. Importance of glutamine metabolism in murine macrophages and human monocytes to L-arginine biosynthesis and rates of nitrite or urea production. , 1998, Clinical science.
[49] R. Cannon. Role of nitric oxide in cardiovascular disease: focus on the endothelium. , 1998, Clinical chemistry.
[50] G. Pieper,et al. Plasma and vascular tissue arginine are decreased in diabetes: acute arginine supplementation restores endothelium-dependent relaxation by augmenting cGMP production. , 1997, The Journal of pharmacology and experimental therapeutics.
[51] C. J. McGrath,et al. Effect of exchange rate return on volatility spill-over across trading regions , 2012 .
[52] T. Cruz,et al. Reactive Oxygen Species Mediate Cytokine Activation of c-Jun NH2-terminal Kinases* , 1996, The Journal of Biological Chemistry.
[53] A. Quyyumi,et al. Role of Endothelium‐Derived Nitric Oxide in the Abnormal Endothelium‐Dependent Vascular Relaxation of Patients With Essential Hypertension , 1993, Circulation.
[54] J. Sowers. Insulin resistance and hypertension , 1990, Molecular and Cellular Endocrinology.
[55] J. Palmer,et al. Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects. , 1976, The Journal of clinical investigation.